Is HTGC a Buy? What to Consider in 2026
Last updated July 2026
Short answer
The bull case for Hercules Capital (HTGC) rests on Record originations and portfolio growth: Hercules set an all-time high in new debt and equity commitments of roughly $1.81 billion in Q1 2026, and net debt portfolio growth of about $298 million pushed total investment income to a record near $141.5 million. Dividend yield is ~12%. If you believe that thesis holds, the real questions become position sizing and overlap, not timing. The main risk to that view: Hercules lends to high-growth, frequently unprofitable venture-backed companies, so a weak venture funding environment or recession could drive rising nonaccruals and net asset value markdowns. Whether HTGC is a buy comes down to whether you believe the thesis. This is informational, not a recommendation, and Walnut is not an investment adviser.
Hercules Capital is a business development company (BDC) that provides senior secured, mostly first-lien loans to venture-capital-backed companies in technology and life sciences. It is recognized as the largest non-bank venture lender, having committed more than $27 billion to over 700 companies since inception, with over $6 billion in assets under management. Roughly 90% of its portfolio is senior secured and floating-rate, with portfolio yields averaging near 13.9%, and individual loans typically sized around $20 million to $40 million. As a BDC, Hercules must distribute most of its taxable income, which is why the stock is held primarily for income. The investment picture centers on yield, credit quality, and rate sensitivity. Because loans float, income rose sharply as benchmark rates climbed, and Hercules has posted record commitments and rising investment income into 2026. The counterweights are that falling rates would compress the yield, its borrowers are often young and unprofitable companies whose credit can deteriorate in a downturn, and the shares frequently trade at a meaningful premium to net asset value, which raises the bar for new capital. Nonaccruals have stayed low, and dividend coverage has been strong, but the model concentrates risk in the venture ecosystem.
What's the case for buying HTGC?
1. Record originations and portfolio growth
Hercules set an all-time high in new debt and equity commitments of roughly $1.81 billion in Q1 2026, and net debt portfolio growth of about $298 million pushed total investment income to a record near $141.5 million. Continued VC and bank pullback has left venture-backed companies seeking non-bank lenders, expanding Hercules's addressable market.
2. Floating-rate, senior-secured income engine
About 90% of the portfolio is senior secured and floating-rate, with yields averaging near 13.9%. This structure lifted net investment income to roughly $0.48 per share in Q1 2026, up about 13.8% year over year, covering the base cash distribution around 120%. Warrant and equity positions can add episodic upside when portfolio companies exit.
3. Strong dividend coverage and credit metrics
The base dividend was covered roughly 120% by first-quarter net investment income, and nonaccruals at fair value sat near 0.1% of the total investment portfolio. A supplemental distribution on top of the base has let Hercules pass through excess earnings while keeping the core payout well protected.
4. Scale and internal management
Hercules is one of the few internally managed BDCs, which avoids the external-manager fee drag that weighs on many peers and can support a lower cost structure per dollar of assets. Its scale, brand, and long track record in venture lending give it access to deal flow that smaller venture-debt BDCs struggle to match.
What are the risks to HTGC?
Hercules lends to high-growth, frequently unprofitable venture-backed companies, so a weak venture funding environment or recession could drive rising nonaccruals and net asset value markdowns. Because roughly 90% of the book is floating-rate, falling benchmark interest rates would compress portfolio yields and pressure net investment income and the dividend. The shares have often traded at a large premium to net asset value (recently around 30%, down from over 70% in 2024), which adds valuation risk if the premium compresses. Operating expenses rose sharply year over year, and like all BDCs, Hercules relies on continued access to debt and equity markets to fund portfolio growth. Net asset value per share slipped to about $11.90 at March 31, 2026, from $12.13 at year-end 2025.
How is HTGC valued? (as of JULY 2026)
Snapshot for HTGC as of July 2026, sourced from Yahoo Finance and may be delayed. Valuation figures move with price and earnings; verify the current numbers with your broker before deciding.
- Total investment income (Q1 2026): ~$141.5M
- Net investment income (Q1 2026): ~$88.1M (~$0.48/share)
- Net asset value per share: ~$11.90 (Mar 31 2026)
- Market cap: ~$2.8B
- Dividend yield: ~12%
- Premium to NAV: ~30%
Hercules generated record total investment income of about $141.5 million in Q1 2026, up roughly 22.5% year over year, with net investment income near $0.48 per share. The stock recently traded around the mid-teens, down double digits year to date, at roughly a 30% premium to net asset value, which is well below the 70%-plus premium seen in 2024. Its high yield reflects both the floating-rate portfolio and the market's pricing of venture-credit risk.
How do you decide if HTGC is a buy?
Rather than asking whether HTGC is a buy in the abstract, it tends to help to answer four questions:
- Thesis: do you believe the case above, and is it still true today?
- Time horizon: a single stock can be volatile, so a longer horizon absorbs more of the swings.
- Position sizing: a thesis can be right and the sizing still wrong; decide how much of your portfolio one name should be.
- Overlap: check whether you already hold HTGC indirectly through an index or sector ETF before adding more.
For the full picture, see the HTGC stock guide (what the company does, the ETFs that hold it, similar stocks, and the themes it fits). In Walnut you can ask its AI about HTGC against your real portfolio and see your actual exposure before deciding.
The bottom line on HTGC
The bottom line: Hercules Capital's story right now is Record originations and portfolio growth, with dividend yield at ~12%. If you believe that narrative continues, the call is about sizing HTGC sensibly and checking overlap with what you own; if you doubt it (the risk: hercules lends to high-growth, frequently unprofitable venture-backed companies, so a weak venture funding environment or recession could drive rising nonaccruals and net asset value markdowns.), it is not for you. Decide from the thesis, not the ticker. Walnut is not an investment adviser.
More on HTGC
- HTGC stock guide (what the company does, ETFs that hold it, similar stocks, and the themes it fits)
- HTGC stock forecast (the drivers and risks shaping the outlook)
- Does HTGC pay a dividend?
Build a basket around HTGC with Walnut
Use Hercules Capital as one constituent in a thematic basket Walnut's AI helps you assemble. Describe a thesis you believe in, the AI proposes the holdings and weights, and you approve before any broker order.
FAQ
Is HTGC a good stock to buy right now?
+
The case for Hercules Capital right now is Record originations and portfolio growth, with dividend yield at ~12%. If you believe that thesis holds, HTGC is a way to own it and the real questions are sizing and overlap, not timing; the main risk to that view is hercules lends to high-growth, frequently unprofitable venture-backed companies, so a weak venture funding environment or recession could drive rising nonaccruals and net asset value markdowns. So it comes down to whether you believe the thesis. Walnut is not an investment adviser and this is not a recommendation.
What does Hercules Capital do?
+
Hercules Capital is a business development company (BDC) that provides senior secured, mostly first-lien loans to venture-capital-backed companies in technology and life sciences.
What are the main risks of HTGC?
+
Hercules lends to high-growth, frequently unprofitable venture-backed companies, so a weak venture funding environment or recession could drive rising nonaccruals and net asset value markdowns. Because roughly 90% of the book is floating-rate, falling benchmark interest rates would compress portfolio yields and pressure net investment income and the dividend. The shares have often traded at a large premium to net asset value (recently around 30%, down from over 70% in 2024), which adds valuation risk if the premium compresses. Operating expenses rose sharply year over year, and like all BDCs, Hercules relies on continued access to debt and equity markets to fund portfolio growth. Net asset value per share slipped to about $11.90 at March 31, 2026, from $12.13 at year-end 2025.
What does Hercules Capital do?
+
Hercules Capital is a business development company (BDC) that makes senior secured, mostly first-lien loans to venture-capital-backed companies in technology and life sciences. It is the largest non-bank venture lender, having committed over $27 billion to more than 700 companies since inception.
Why does HTGC have such a high dividend yield?
+
As a BDC, Hercules must distribute most of its taxable income to shareholders, and its portfolio of floating-rate venture loans earns yields averaging near 13.9%. That combination has recently produced a dividend yield around 12%, including a base distribution plus a supplemental.
Is the HTGC dividend well covered?
+
In Q1 2026, net investment income of roughly $0.48 per share covered the base cash distribution about 120%, and nonaccruals were near 0.1% of the portfolio at fair value. Coverage has been strong, though a sharp drop in rates or a rise in credit losses could pressure it.
What is Hercules Capital's net asset value?
+
Net asset value was about $11.90 per share as of March 31, 2026, down from $12.13 at year-end 2025. The stock has often traded at a premium to this figure, recently around 30%, meaning buyers pay more than the underlying portfolio's stated value.
Walnut is informational and is not an investment adviser. This page is educational and not a recommendation to buy or sell HTGC; figures are approximate and dated, and your own situation, time horizon, and risk tolerance should drive any decision. Verify current data before investing.